3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Leukemia, Myeloid, Acute
32
Myelodysplastic Syndromes
28
Multiple Myeloma
28
Precursor Cell Lymphoblastic Leukemia-Lymphoma
26
Hodgkin Disease
12
Leukemia, Myelogenous, Chronic, BCR-ABL Positive
11
Lymphoma, Non-Hodgkin
10
Lymphoma
10
Hematologic Neoplasms
10
Neuroblastoma
9
Myeloproliferative Disorders
9
Anemia, Refractory, with Excess of Blasts
8
Lymphoma, Mantle-Cell
7
Leukemia, Myelomonocytic, Chronic
7
Leukemia
7
Neoplasms, Plasma Cell
6
Lymphoma, T-Cell
6
Leukemia, Biphenotypic, Acute
6
Graft vs Host Disease
6
Leukemia, Lymphocytic, Chronic, B-Cell
5
Burkitt Lymphoma
5
Recurrence
4
Primary Myelofibrosis
4
Melanoma
4
Lymphoma, Large B-Cell, Diffuse
4
Lymphoma, Follicular
4
Leukemia, Myelomonocytic, Juvenile
4
Hematologic Diseases
4
Ganglioneuroblastoma
4
Anemia, Aplastic
4
Interventions
tremelimumab
4
Ipilimumab
4
lenvatinib
3
durvalumab
3
Nivolumab
3
pembrolizumab
2
balstilimab
2
Pemetrexed
2
Carboplatin
2
Bevacizumab
2
spartalizumab
1
relatlimab
1
poly ICLC
1
osimertinib
1
cemiplimab
1
Vemurafenib
1
Vascular Endothelial Growth Factor A
1
Standard of Care
1
Platinum
1
Peptides
1
Paclitaxel
1
Opdualag
1
Docetaxel
1
Capecitabine
1
Blood Specimen Collection
1
Axitinib
1
Antibodies, Bispecific
1
130-nm albumin-bound paclitaxel
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Diabetes Mellitus, Insulin-Dependent, 12
×
Melphalan
×
1 year
×
Clear all
No trials found.